An investigation of the ability of oral naloxone to correct opioid-related constipation in patients with advanced cancer

Palliative Medicine

Volumn 10, Issue 2, 1996, Pages 135-144

  Sykes, N P ^a,b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b ST CHRISTOPHER S HOSPICE   (United Kingdom)

Author keywords

Cathartics; Constipation; Naloxone; Opioids; Palliative treatment

Indexed keywords

DIAMORPHINE; MORPHINE SULFATE; NALOXONE; NARCOTIC ANTAGONIST; OPIATE;

ADVANCED CANCER; ARTICLE; CANCER PAIN; CANCER PALLIATIVE THERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HUMAN; HYDROGEN BREATH TEST; INTESTINE TRANSIT TIME; NAUSEA; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; WITHDRAWAL SYNDROME;

EID: 0029878393     PISSN: 02692163     EISSN: None     Source Type: Journal    
DOI: 10.1177/026921639601000208     Document Type: Article

References (25)

1. Twycross RG, Lack SA. Constipation. In: Control of alimentary symptoms in far advanced cancer. Edinburgh: Churchill Livingstone, 1986: 172-77.
2. Heel RC, Brogden RN, Speight TM, Avery GA. Loperamide: a review of its pharmacological properties and therapeutic efficacy in diarrhoea. Drugs 1978; 15: 33-52.
3. Kromer W. Endogenous and exogenous opioids in the control of gastrointestinal motility and secretion. Pharmacol Rev 1988; 40: 123-50.
4. Fishman J, Roffwarg H, Helman L. Disposition of naloxone-7,8-3H in normal and narcotic-dependent men. J Pharmacol Exp Ther 1973; 187: 575-80.
5. Basilisco G, Camboni G, Bozzani A, Paravicini M, Bianchi PA. Oral naloxone antagonizes loperamide-induced delay of oro-caecal transit. Dig Dis Sci 1987; 32: 829-32.
6. Culpepper-Morgan J, Inturissi C, Portenoy R, Kreek MJ. Oral naloxone treatment of narcotic induced constipation: dose response. NIDA Res Monogr 1989; 95: 399-409.
7. Bianchi G, Ferretti P, Recchia M, Rocchetti M, Tavani A, Manara L. Morphine tissue levels and reduction of gastrointestinal transit in rats. Gastroenterol 1983; 85: 852-8.
8. Wong C-L, Roberts MB, Wai M-K. Effect of morphine and naloxone on intestinal transit in mice. Eur J Pharmacol 1980; 64: 289-95.
9. Parolaro D, Sala M, Gori E. Effect of intracerebroventricular administration of morphine upon intestinal motility in rats and its antagonism with naloxone. Eur J Pharmacol 1977; 46: 329-38.
10. Sykes NP, Oral naloxone in opioid-associated constipation. Lancet 1991; 337: 1475.
11. Bond JH, Levitt MD. Investigation of small bowel transit time in man utilizing pulmonary hydrogen measurements. J Lab Clin Med 1975; 85: 546-55.
12. Metz G, Gassull MA, Leeds AR, Blendis LM, Jenkins DJA. A simple method of measuring breath hydrogen in carbohydrate malabsorption by end-expiratory sampling. Clin Sci Mol Med 1976; 50: 237-40.
13. La Brooy SJ, Male PJ, Breavis AK, Misiewicz JJ. Assessment of the reproducibility of the lactulose hydrogen breath test as a measure of mouth to caecum transit time. Gut 1983; 24: 893-6.
14. Staniforth DH. Comparison of orocaecal transit times assessed by the lactulose/breath hydrogen and sulphasalazine/sulphapyridine methods. Gut 1989; 30: 978-82.
15. Manara L, Bianchi G, Ferretti P, Monferini E, Strada D, Tavani A. Local and CNS-mediated effects of morphine and narcotic antagonists on gastrointestinal propulsion in rats. In: Leong Way E ed. Endogenous and exogenous opiate agonists and antagonists. New York: Pergamon, 1980; 143-6.
16. Green AF. Comparative effects of analgesics on pain threshold, respiratory frequency and gastrointestinal propulsion. Brit J Pharmacol 1959; 14: 26-34.
17. Peracchia F, Bianchi G, Fiocchi R, Petrillo P, Tavani A, Manara L. Central and peripheral inhibition of gastrointestinal transit in rats: narcotics differ substantially by acting at either or both levels. J Pharm Pharmacol 1984; 36: 699-701.
18. Shannon HE, Holtzman SG. Blockade of the discriminative effects of morphine in the rat by naltrexone and naloxone. Psychopharmacol 1976; 50: 119-24.
19. Culpepper-Morgan J, LaRoche D, Nguyen J, Lewis VO, Kreek MJ. Orally administered opioid antagonists reverse both mu and kappa agonist delay of oro-cecal transit in the guinea pig. American Association of Physicians, Proc Spring Meeting 1989.
20. Jurna I, Kaiser R, Kretz O, Baldauf J. Oral naloxone reduces constipation but not antinociception from oral morphine in the rat. Neurosc [Letters] 1992; 142: 62-4.
21. Kreek MJ. Plasma and urine levels of methadone. Comparison following four medication forms used in chronic maintenance treatment. NY State J Med 1973; 73: 2773-7.
22. Culpepper-Morgan J, Inturrisi C, Portenoy R, Foley K, Honde R, Marsh F, Kreek MJ. Treatment of opioid-induced constipation with oral naloxone: a pilot study. Clin Pharmocol Ther 1992; 52: 90-5.
23. Sykes NP. A clinical comparison of laxatives in a hospice. Palliat Med 1991; 5: 307-14.
24. Wikler A, Fraser HF, Isbell H. N-allylnormorphine: effects of single doses and precipitation of acute abstinence syndromes during addiction to morphine, methadone or heroin in man. J Pharmacol Exp Ther 1953; 109: 8-20.
25. Andrews HL, Himmelsbach CK. Relation of the intensity of the morphine abstinence syndrome to dosage. J Pharmacol Exp Ther 1944; 81: 288-93.